Skip to main content
. 2022 Oct 24;13:1003859. doi: 10.3389/fimmu.2022.1003859

Figure 4.

Figure 4

Dynamics of cancer antigen 19-9/125 levels during the entire disease course. T, Trastuzumab; DCS, docetaxel + cisplatin+S-1; FOLFIRI, folinic acid + fluorouracil + irinotecan.